These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30413340)

  • 1. Risk-based stratification of carcinomas concurrently involving the endometrium and ovary.
    Turashvili G; Gómez-Hidalgo NR; Flynn J; Gonen M; Leitao MM; Soslow RA; Murali R
    Gynecol Oncol; 2019 Jan; 152(1):38-45. PubMed ID: 30413340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
    Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
    J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous dual primary ovarian and endometrial carcinomas.
    Pearl ML; Johnston CM; Frank TS; Roberts JA
    Int J Gynaecol Obstet; 1993 Dec; 43(3):305-12. PubMed ID: 7907042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.
    Yoneoka Y; Yoshida H; Ishikawa M; Shimizu H; Uehara T; Murakami T; Kato T
    J Gynecol Oncol; 2019 Jan; 30(1):e7. PubMed ID: 30479091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.
    Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M
    Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
    Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
    Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of sentinel lymph node mapping for patients with FIGO stage I endometrioid endometrial carcinoma.
    Nasioudis D; Byrne M; Ko EM; Giuntoli RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Latif NA
    Gynecol Oncol; 2021 Jun; 161(3):705-709. PubMed ID: 33771397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
    Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
    Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
    Zhan X; Li L; Wu M; Lang J
    Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study.
    Caldarella A; Crocetti E; Taddei GL; Paci E
    Pathol Res Pract; 2008; 204(9):643-8. PubMed ID: 18472354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
    Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous endometrioid carcinoma of the uterine corpus and ovary. A case report and review of the literature.
    Grammatoglou X; Skafida E; Glava C; Katsamagkou E; Delliou E; Vasilakaki T
    Eur J Gynaecol Oncol; 2009; 30(4):437-9. PubMed ID: 19761140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
    Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
    Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous squamous cell carcinoma of the endometrium and endometrioid adenocarcinoma of the ovary.
    Grigoriadis C; Androutsopoulos G; Zygouris D; Arnogiannaki N; Terzakis E
    Eur J Gynaecol Oncol; 2012; 33(6):666-8. PubMed ID: 23327069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous Endometrial and Ovarian Carcinomas: Pathologic and Molecular Analysis Highlights the Monoclonal Origin of the Lesions.
    Guerriero A; Moro M; Angerilli V; Munari G; Santoro L; Alessandrini L; Favero L; Tasca G; Fassan M; Dei Tos AP
    Int J Gynecol Pathol; 2024 Jul; 43(4):309-315. PubMed ID: 37922918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.